Skip Navigation

JNCI Journal of the National Cancer Institute 2003 95(17):1258-1261; doi:10.1093/jnci/djg063
© 2003 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (23)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Quinn, M.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Quinn, M.J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2003 Oxford University Press

EDITORIAL

Cancer Trends in the United States—A View From Europe

M.J. Quinn

Correspondence to: Director, National Cancer Intelligence Centre, Office for National Statistics, B7/04, 1 Drummond Gate, London, SW1V 2QQ, U.K. (e-mail: mike.quinn@ons.gov.uk).

The first 150 words of the full text of this article appear below.

The fifth in the series of Annual Reports to the Nation on the Status of Cancer (1) focuses on the four most common cancers—lung, female breast, colorectal, and prostate—that together account for more than half of both cancer cases and deaths in the United States. These four cancers have similar importance in most of Europe (2). A principal strength of the report is that it provides a wealth of information on the cancer trends in terms of both incidence and mortality. Incidence and mortality data each have their own advantages and disadvantages (Table 1Go).


View this table:
[in this window]
[in a new window]
  		Table 1. Advantages and disadvantages of cancer incidence and mortality data
 
More than 20 years ago, Doll and Peto (3), using data from studies done in the 1970s and earlier, concluded that mortality data were generally more trustworthy than incidence data. However, cancer registration data from the globally renowned Surveillance, . . . [Full Text of this Article]

LUNG CANCER TRENDS

BREAST CANCER TRENDS

PROSTATE CANCER TRENDS

COLORECTAL CANCER TRENDS

FUTURE REDUCTIONS IN CANCER MORTALITY


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Health Aff (Millwood)Home page
K. E. Thorpe, D. H. Howard, and K. Galactionova
Differences In Disease Prevalence As A Source Of The U.S.-European Health Care Spending Gap
Health Aff., November 1, 2007; 26(6): w678 - w686.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
V Esposito, A Baldi, A De Luca, G Tonini, B Vincenzi, D Santini, P Persichetti, A Mancini, G Citro, F Baldi, et al.
Cell cycle related proteins as prognostic parameters in radically resected non-small cell lung cancer
J. Clin. Pathol., July 1, 2005; 58(7): 734 - 739.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
B. C. Yankaskas, S. H. Taplin, L. Ichikawa, B. M. Geller, R. D. Rosenberg, P. A. Carney, K. Kerlikowske, R. Ballard-Barbash, G. R. Cutter, and W. E. Barlow
Association between Mammography Timing and Measures of Screening Performance in the United States
Radiology, February 1, 2005; 234(2): 363 - 373.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
P. A. Carney, D. W. Nierenberg, C. F. Pipas, W. B. Brooks, T. A. Stukel, and A. M. Keller
Educational Epidemiology: Applying Population-Based Design and Analytic Approaches to Study Medical Education
JAMA, September 1, 2004; 292(9): 1044 - 1050.
[Abstract] [Full Text] [PDF]